Nevertheless, we anticipate that the development of drugs targeting the cGAS–STING pathway and their translation into clinical applications in the near future will help further ameliorate the condition of patients with cancer, inflammation, and autoimmune diseases. This evidence concerns the gene CGAS and cancer.